Cargando…

Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints

BACKGROUND: Recently, several adaptive one-arm two-stage designs have been developed by fully using the information from previous stages to reduce the expected sample size in clinical trials with binary endpoints as primary outcome. It is important to compute exact confidence limits for these studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Guogen, Zhang, Hua, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294881/
https://www.ncbi.nlm.nih.gov/pubmed/28166741
http://dx.doi.org/10.1186/s12874-017-0297-5
_version_ 1782505325435289600
author Shan, Guogen
Zhang, Hua
Jiang, Tao
author_facet Shan, Guogen
Zhang, Hua
Jiang, Tao
author_sort Shan, Guogen
collection PubMed
description BACKGROUND: Recently, several adaptive one-arm two-stage designs have been developed by fully using the information from previous stages to reduce the expected sample size in clinical trials with binary endpoints as primary outcome. It is important to compute exact confidence limits for these studies. METHODS: In this article, we propose three new one-sided limits by ordering the sample space based on p-value, average response rate at each stage, and asymptotic lower limit, as compared to another three existing sample size ordering approaches based on average response rate. Among the three proposed approaches, the one based on the average response rate at each stage is not exact, and the remaining two approaches are exact with the coverage probability guaranteed. RESULTS: We compare these exact intervals by using the two commonly used criteria: simple average length and expected length. The existing three approaches based on average response rate have similar performance, and they have shorter expected lengths than the two proposed exact approaches although the gain is small, while this trend is reversed under the simple average criterion. CONCLUSIONS: We would recommend the two exact proposed approaches based on p-value and asymptotic lower limit under the simple average length criterion, and the approach based on average response rate under the expected length criterion.
format Online
Article
Text
id pubmed-5294881
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52948812017-02-09 Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints Shan, Guogen Zhang, Hua Jiang, Tao BMC Med Res Methodol Research Article BACKGROUND: Recently, several adaptive one-arm two-stage designs have been developed by fully using the information from previous stages to reduce the expected sample size in clinical trials with binary endpoints as primary outcome. It is important to compute exact confidence limits for these studies. METHODS: In this article, we propose three new one-sided limits by ordering the sample space based on p-value, average response rate at each stage, and asymptotic lower limit, as compared to another three existing sample size ordering approaches based on average response rate. Among the three proposed approaches, the one based on the average response rate at each stage is not exact, and the remaining two approaches are exact with the coverage probability guaranteed. RESULTS: We compare these exact intervals by using the two commonly used criteria: simple average length and expected length. The existing three approaches based on average response rate have similar performance, and they have shorter expected lengths than the two proposed exact approaches although the gain is small, while this trend is reversed under the simple average criterion. CONCLUSIONS: We would recommend the two exact proposed approaches based on p-value and asymptotic lower limit under the simple average length criterion, and the approach based on average response rate under the expected length criterion. BioMed Central 2017-02-06 /pmc/articles/PMC5294881/ /pubmed/28166741 http://dx.doi.org/10.1186/s12874-017-0297-5 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Shan, Guogen
Zhang, Hua
Jiang, Tao
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
title Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
title_full Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
title_fullStr Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
title_full_unstemmed Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
title_short Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
title_sort efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294881/
https://www.ncbi.nlm.nih.gov/pubmed/28166741
http://dx.doi.org/10.1186/s12874-017-0297-5
work_keys_str_mv AT shanguogen efficientconfidencelimitsforadaptiveonearmtwostageclinicaltrialswithbinaryendpoints
AT zhanghua efficientconfidencelimitsforadaptiveonearmtwostageclinicaltrialswithbinaryendpoints
AT jiangtao efficientconfidencelimitsforadaptiveonearmtwostageclinicaltrialswithbinaryendpoints